We are live on ! Find out more
VTRS icon

Viatris

995 hedge funds and large institutions have $10.4B invested in Viatris in 2024 Q2 according to their latest regulatory filings, with 86 funds opening new positions, 319 increasing their positions, 386 reducing their positions, and 82 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more call options, than puts

Call options by funds: $35.7M | Put options by funds: $26.6M

5% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 82

0.92% more ownership

Funds ownership: 81.2%82.12% (+0.92%)

0% more funds holding in top 10

Funds holding in top 10: 1111 (0)

1% less funds holding

Funds holding: 1,008995 (-13)

10% less capital invested

Capital invested by funds: $11.5B → $10.4B (-$1.11B)

17% less repeat investments, than reductions

Existing positions increased: 319 | Existing positions reduced: 386

Holders
995
Holders Change
-13
Holders Change %
-1.29%
% of All Funds
14.37%
Holding in Top 10
11
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.16%
New
86
Increased
319
Reduced
386
Closed
82
Calls
$35.7M
Puts
$26.6M
Net Calls
+$9.18M
Net Calls Change
-$9.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.49B -$13.3M -1,202,678 -0.8%
BlackRock
2
BlackRock
New York
$985M -$7.35M -664,777 -0.7%
State Street
3
State Street
Massachusetts
$660M -$7.19M -651,167 -1%
DSA
4
Davis Selected Advisers
Arizona
$612M +$780K +70,554 +0.1%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$604M -$11.7M -1,061,401 -2%
Pacer Advisors
6
Pacer Advisors
Pennsylvania
$407M +$131M +11,896,333 +45%
Invesco
7
Invesco
Georgia
$326M -$5.86M -529,988 -2%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$307M +$5.26M +476,468 +2%
Ameriprise
9
Ameriprise
Minnesota
$232M +$13.8M +1,248,374 +6%
DM
10
Deerfield Management
New York
$227M +$4.91K +444 +0%
RCMNY
11
Rubric Capital Management (New York)
New York
$214M +$18.8M +1,702,272 +9%
Morgan Stanley
12
Morgan Stanley
New York
$182M +$30.5M +2,763,740 +19%
CCM
13
Camber Capital Management
Massachusetts
$159M -$13.8M -1,250,000 -8%
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$147M +$24.6M +2,228,736 +19%
A
15
AustralianSuper
Australia
$142M +$27.9M +2,527,102 +23%
Norges Bank
16
Norges Bank
Norway
$134M -$2.67M -241,409 -2%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$122M +$299K +27,039 +0.2%
Charles Schwab
18
Charles Schwab
California
$122M +$1.28M +115,409 +1%
Northern Trust
19
Northern Trust
Illinois
$118M +$1.56M +141,198 +1%
Legal & General Group
20
Legal & General Group
United Kingdom
$104M +$7.75M +701,491 +8%
LSV Asset Management
21
LSV Asset Management
Illinois
$102M -$2.36M -213,495 -2%
Nordea Investment Management
22
Nordea Investment Management
Sweden
$93.1M +$52.1M +4,711,456 +117%
Schroder Investment Management Group
23
Schroder Investment Management Group
United Kingdom
$86.9M -$11M -996,452 -11%
Amundi
24
Amundi
France
$83.3M -$11.2M -1,017,056 -11%
Fidelity Investments
25
Fidelity Investments
Massachusetts
$83M +$47M +4,250,584 +120%

VTRS Hedge Fund Activity: Q2 2024 in Review

995 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Viatris (VTRS) for Q2 2024, worth a combined $10.4B — down 9.7% from $11.5B a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new VTRS positions and 82 closed out — a net gain of 4 holders — while 319 added to existing stakes and 386 trimmed.

The largest buyer was Pacer Advisors, adding an estimated $131M. The largest seller was Slate Path Capital, exiting entirely with an estimated $129M sold.

  • 995 institutional investors held Viatris (VTRS) as of Q2 2024, down from 1,008 in Q1 2024.
  • Funds reported $10.4B of Viatris stock for Q2 2024, down 9.7% quarter-over-quarter.
  • 86 funds opened new Viatris positions in Q2 2024 and 82 closed out, a net change of +4 holders.
  • The largest Viatris buyer in Q2 2024 was Pacer Advisors, an estimated $131M added.
  • The largest Viatris seller in Q2 2024 was Slate Path Capital, an estimated $129M sold.

Based on aggregated 13F filings for Q2 2024.